Early use of intravitreal triamcinolone to inhibit traumatic proliferative vitreoretinopathy: a randomised clinical trial

CONCLUSIONS: Early intravitreal TA injection for OGI effectively reduces TPVR, increases surgical success and improves visual prognosis.PMID:38041678 | DOI:10.1136/bjo-2023-324318
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research